Shares of Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) rose 6.5% during trading on Monday . The company traded as high as $2.54 and last traded at $2.47. Approximately 48,083 shares changed hands during mid-day trading, an increase of 61% from the average daily volume of 29,836 shares. The stock had previously closed at […]
Protara Therapeutics (NASDAQ:TARA – Free Report) and VectivBio (NASDAQ:VECT – Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of current recommendations for Protara […]
Opaleye Management Inc. decreased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,692,594 shares of the company’s stock after selling 15,473 shares during the period. Protara Therapeutics comprises about 2.5% of […]
Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 102,200 shares, a growth of 34.1% from the April 15th total of 76,200 shares. Approximately 1.2% of the shares of the company are sold short. Based on […]
Protara Therapeutics, Inc. (NASDAQ:TARA – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 102,200 shares, an increase of 34.1% from the April 15th total of 76,200 shares. Approximately 1.2% of the company’s stock are sold short. Based […]